The N-methyl-D-aspartate receptor splice variant NR1-4 C-terminal domain. Deletion analysis and role in subcellular distribution.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 11700309)

Published in J Biol Chem on November 07, 2001

Authors

Kevin D Holmes1, Pierre A Mattar, Daniel R Marsh, Lynne C Weaver, Gregory A Dekaban

Author Affiliations

1: Gene Therapy and Molecular Virology Group, Department of Microbiology and Immunology, the University of Western Ontario, London, Ontario N6A 5K8, Canada.

Articles by these authors

The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01

Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci (2004) 1.80

A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma (2010) 1.54

RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages. PLoS Pathog (2008) 1.49

Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil (2007) 1.35

A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13

Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention. Prog Brain Res (2006) 1.11

Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem (2004) 1.11

Chronic pain after clip-compression injury of the rat spinal cord. Exp Neurol (2002) 1.10

A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma (2010) 1.10

The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08

CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes (2007) 1.05

The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol (2008) 1.04

Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Res (2008) 1.02

Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma (2010) 1.02

Neutralizing intraspinal nerve growth factor with a trkA-IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury. J Neurotrauma (2002) 1.01

Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J Neurosci (2005) 1.00

Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro. J Clin Pharmacol (2005) 0.98

NGF message and protein distribution in the injured rat spinal cord. Exp Neurol (2004) 0.97

Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem (2005) 0.95

Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol (2008) 0.95

Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J Neurotrauma (2005) 0.94

Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp Neurol (2008) 0.94

The dark side of neuroplasticity. Exp Neurol (2011) 0.93

Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res (2007) 0.93

An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem (2004) 0.93

A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats. J Neurotrauma (2012) 0.92

An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol (2008) 0.91

Origins of R2* orientation dependence in gray and white matter. Proc Natl Acad Sci U S A (2013) 0.91

Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images. J Magn Reson Imaging (2007) 0.91

Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion. J Neuroinflammation (2013) 0.91

Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J Neuropathol Exp Neurol (2012) 0.90

Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy. J Neurosurg Spine (2009) 0.90

NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol (2007) 0.89

Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol (2006) 0.89

Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized. J Virol (2009) 0.88

CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol (2011) 0.88

A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury. J Neurotrauma (2011) 0.86

Autonomic dysreflexia, induced by noxious or innocuous stimulation, does not depend on changes in dorsal horn substance p. J Neurotrauma (2004) 0.85

Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2. Virology (2009) 0.85

Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury. J Neurosci Res (2009) 0.85

Central mechanisms for autonomic dysreflexia after spinal cord injury. Prog Brain Res (2002) 0.85

What causes autonomic dysreflexia after spinal cord injury? Clin Auton Res (2002) 0.85

The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade. J Neurotrauma (2012) 0.85

Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits. Virus Res (2009) 0.84

Cellular imaging of inflammation after experimental spinal cord injury. Mol Imaging (2005) 0.84

A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. J Neurosurg Spine (2006) 0.84

Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J Neuroimmunol (2013) 0.83

Gene expression profiling in anti-CD11d mAb-treated spinal cord-injured rats. J Neuroimmunol (2009) 0.83

Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. Contrast Media Mol Imaging (2011) 0.83

In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol Imaging Biol (2011) 0.83

Effects of spinal cord injury on synaptic inputs to sympathetic preganglionic neurons. Prog Brain Res (2006) 0.82

CD11d Antibody Treatment Improves Recovery in Spinal Cord-Injured Mice. J Neurotrauma (2011) 0.82

Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes. J Neurotrauma (2011) 0.82

Development of autonomic dysreflexia after spinal cord injury is associated with a lack of serotonergic axons in the intermediolateral cell column. J Neurotrauma (2010) 0.82

Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat. J Pharmacol Exp Ther (2005) 0.82

Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. Cytotherapy (2011) 0.81

HIV Tat potentiates cell toxicity in a T cell model for sulphamethoxazole-induced adverse drug reactions. Virus Genes (2009) 0.81

Comparison of effects of methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury. Exp Neurol (2005) 0.81

Aging-associated oxidative stress modulates the acute inflammatory response in skeletal muscle after contusion injury. Exp Gerontol (2010) 0.81

Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes. Inflamm Res (2010) 0.80

Role of polysialylated neural cell adhesion molecule in rapid eye movement sleep regulation in rats. Eur J Neurosci (2009) 0.80

Dendritic cell internalization of foam-structured fluorescent mesoporous silica nanoparticles. J Colloid Interface Sci (2010) 0.80

Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes. Int Immunol (2011) 0.80

Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development. Cytotechnology (2005) 0.79

On the phylogenetic placement of human T cell leukemia virus type 1 sequences associated with an Andean mummy. Infect Genet Evol (2005) 0.79

Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways. Virol J (2013) 0.78

Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation. J Neurosurg Spine (2008) 0.78

Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity. Virology (2008) 0.78

Effects of a novel tripeptide on neurological outcomes after spinal cord injury. Neuroreport (2006) 0.78

Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada. Infect Genet Evol (2012) 0.77

Adverse drug reactions to protease inhibitors. Can J Clin Pharmacol (2002) 0.77

The extracellular domain of CD11d regulates its cell surface expression. J Leukoc Biol (2009) 0.76

Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury. Exp Neurol (2011) 0.76

Ischaemia-reperfusion modulates inflammation and fibrosis of skeletal muscle after contusion injury. Int J Exp Pathol (2010) 0.75

An antisense construct reduces N-methyl-D-aspartate receptor 2A expression and receptor-mediated excitotoxicity as determined by a novel flow cytometric approach. J Neurosci Res (2003) 0.75